Their 2 phase 3 trials hit there primary end points agonist the oral MS drug Teriflunomide. They have an SPA with the FDA.This for a trade against the PDUFA date.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.